Skip to main content

Table 7 Comparison between case and control groups as regards creatinine (mg/dL)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

Creatinine Group A Group B A/B^
Before Median (IQR) 1.10
(0.83–1.30)
1.15
(0.93–1.30)
0.594
Range 0.60–2.30 0.80–1.80
After Median (IQR) 1.00
(0.73–1.28)
1.30
(1.20–1.50)
0.003*
Range 0.20–2.00 0.80–2.50
Difference Median (IQR) 0.00
(− 0.28–0.10)
0.10
(0.03–0.28)
0.013*
Range − 2.10–1.00 0.00–1.60
p# 0.505 < 0.001*  
  1. Negative values indicate reduction
  2. Md median, IQR interquartile range
  3. ^Mann-Whitney test
  4. #Wilcoxon signed rank test
  5. *Significant